Results 51 to 60 of about 2,201,217 (298)

Wearable Polarization Conversion Metasurface MIMO Antenna for Biomedical Applications in 5 GHz WBAN

open access: yesBiosensors, 2023
This paper presents a wearable metasurface multiple-input multiple-output (MIMO) antenna for biomedical applications in a 5 GHz wireless body area network (WBAN) with broadband, circular polarization (CP), and high gain.
Rigeng Wu, Jian Dong, Meng Wang
doaj   +1 more source

Epigenetic reprogramming of lineage switching in cancer

open access: yesFEBS Letters, EarlyView.
Cancer cells rarely commit to a single identity. Epigenetic mechanisms and tumor microenvironment cues push epithelial cells toward flexible, hybrid states that can shift into mesenchymal, neuroendocrine, or stem‐like fates, driving metastasis, drug resistance, and tumor heterogeneity. Targeting the epigenetic regulators behind these transitions, using
Ezgi Boyvatlı   +4 more
wiley   +1 more source

Comprehensive Review of Hybrid Feature Selection Methods for Microarray-Based Cancer Detection

open access: yesIEEE Access
Microarray data-based cancer detection advances early diagnosis and personalized medicine by utilizing gene expression data to develop comprehensive cancer profiles, measuring thousands of genes simultaneously.
Azka Khoirunnisa   +3 more
doaj   +1 more source

Validating curricular competencies in innovation and entrepreneurship for biomedical research trainees: A modified Delphi approach

open access: yesJournal of Clinical and Translational Science, 2019
Introduction:Biomedical researchers need skills in innovation and entrepreneurship (I&E) to efficiently translate scientific discoveries into products and services to be used to improve health.Methods:In 2016, the European Union identified and published ...
Jane Garbutt   +6 more
doaj   +1 more source

Biomedical optical fibers

open access: yesLab on a Chip, 2021
Tasoglu, Yetisen and co-workers review the emerging medical and health-related applications of optical fibers, illustrating the new wave for the fabrication of implantable devices, wearable sensors, and photodetection and therapy setups.
Misagh Rezapour Sarabi   +4 more
openaire   +3 more sources

Chiral separation of chloroalkanes with the chromatographic column onboard Martian rovers

open access: yesFEBS Letters, EarlyView.
Computer image of the Rosalind Franklin Rover of ESA's ExoMars mission. ExoMars is scheduled to land on planet Mars in Oxia Planum in 2029. This area represents an interesting spot to look for biosignatures. Investigations of ExoMars include measurement on molecular chirality. We show that chiral chloroalkanes, that have been identified on Mars, can be
Asma Merzougui   +4 more
wiley   +1 more source

What is biomedical engineering?: part 1 [Frontiers of biomedical engineering]

open access: yes, 2016
Educação Superior::Engenharias::Engenharia BiomédicaPresents a course with the professor of Chemical and Biomedical Engineering at Yale University, W. Mark Saltzman about Frontiers of Biomedical Engineering.
Saltzman, W. Mark
core   +2 more sources

Circular RNA expression landscapes in myelodysplastic neoplasms: Associations with mutational signatures and disease progression

open access: yesMolecular Oncology, EarlyView.
In this explorative study, the abundance of circular RNA molecules in bone marrow stem cells was found to be elevated in patients with high‐risk myelodysplastic neoplasms, and to be associated with an increased risk of progression to acute myeloid leukemia.
Eileen Wedge   +17 more
wiley   +1 more source

Differential expression of cancer‐related genes supports prediction of poor response to first‐line treatments in T‐ALL pediatric patients with high minimal residual disease

open access: yesMolecular Oncology, EarlyView.
In the present work, we have identified a transcriptional signature based on the differential expression of six genes (BCL2&MAST4, HSH2D&LAT2, METRN&PITPNM2) that would facilitate the early detection of T‐cell acute lymphoblastic leukemia (T‐ALL) patients prone to a poor treatment response and could be implemented at diagnosis, along with other risk ...
Antonio Lahera   +11 more
wiley   +1 more source

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

open access: yesMolecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy